Showing results (11-20 of 89) with videos related to
Sort By:
Pageof 9
Pharmacoeconomics|September 30, 2000
Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trialB Detournay, X Huet, F Fagnani, et al.Health Physics|June 1, 1989
Doses to patients from dental radiology in FranceM Benedittini, C Maccia, C Lefaure, et al.Journal De Radiologie|October 1, 1986
[Collective radiation dosage due to radiodiagnostic practice in France in 1982. Methodology. 1]F Fagnani, C Maccia, M Benedittini, et al.Health Physics|April 1, 1988
Doses to patients from diagnostic radiology in FranceC Maccia, M Benedittini, C Lefaure, et al.Pharmacoeconomics|December 8, 1997
Cost effectiveness of a low-molecular-weight heparin in prolonged prophylaxis against deep vein thrombosis after total hip replacementB Detournay, A Planes, N Vochelle, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|November 26, 1999
Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: a modeling approachR Dardennes, G Berdeaux, A Lafuma, et al.Pharmacoeconomics|August 5, 1998
Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adultsG Berdeaux, A Lafuma, A M Perruchet, et al.European Journal of Radiology|November 1, 1988
Contrasted diffusion and the use of CT scanner equipment in FranceC Le Galès, C Lefaure, F Fagnani, et al.Seizure|June 14, 2000
The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Active Coordination of the Longitudinal Observational Network in EpilepsyM De Zélicourt, L Buteau, F Fagnani, et al.Journal Des Maladies Vasculaires|January 1, 1994
[Venous disease in France: an unrecognized public health problem]A Lafuma, F Fagnani, F Peltier-Pujol, et al.Pageof 9